Sheba Medical Center\u2019s innovation hub, ARC (Accelerate, Redesign, Collaborate), has entered a collaboration with Revealense to advance AI-based neurological diagnostics that can be performed at home. The joint venture will leverage Revealense\u2019s patented behavioral analysis technology, which interprets video footage to deliver clinically validated assessments of neurological, cognitive, and developmental conditions.<\/p>\n\n\n\n
The first protocols, led by Dr. Omer Bar Yosef of Sheba\u2019s Child Development Center, will target autism and ADHD, with the goal of significantly reducing diagnostic delays. Early detection may even allow for initial assessments of developmental conditions between 6 and 12 months of age.<\/p>\n\n\n\n
Unlike traditional clinical methods, the system uses a standard webcam to analyze patients in their home environment. This approach not only improves convenience but also ensures data reflects natural behaviors, enabling more accurate profiling. The AI platform incorporates environmental context, monitors changes over time, and recommends personalized care pathways.<\/p>\n\n\n\n
Revealense CEO Dov Donin described the collaboration as a \u201cparadigm shift\u201d in neurological care, citing its potential to improve accuracy, reduce bias, and accelerate access to treatment. ARC leaders echoed this view, highlighting how Sheba\u2019s global network of more than 300 hospitals can help scale the innovation internationally.<\/p>\n\n\n\n
The venture plans to move rapidly toward regulatory approvals, with market entry targeted for early 2026. By combining Sheba\u2019s clinical expertise with Revealense\u2019s AI engine, the initiative aims to set new standards for accessibility and reliability in neurological diagnostics.<\/p>","protected":false},"excerpt":{"rendered":"
ARC at Sheba Medical Center teams with Revealense to develop webcam-based AI diagnostics for autism, ADHD, and other neurological conditions.<\/p>","protected":false},"author":2,"featured_media":34781,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[681,27,10],"tags":[619],"class_list":["post-34780","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-care-therapy","category-middle-east-africa","category-strategic-development","tag-partnerships"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/posts\/34780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/comments?post=34780"}],"version-history":[{"count":1,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/posts\/34780\/revisions"}],"predecessor-version":[{"id":34782,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/posts\/34780\/revisions\/34782"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/media\/34781"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/media?parent=34780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/categories?post=34780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/ko\/wp-json\/wp\/v2\/tags?post=34780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}